Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mothers against decapentaplegic homolog 2 (SMAD2)
- Target
- SMAD2
- Molecular classification
- Transcription factor, Signal transducer
01
Overview
Mothers against decapentaplegic homolog 2, commonly known as **SMAD family member 2** or **SMAD2**, is a protein encoded by the SMAD2 gene in humans. It acts as a critical intracellular signal transducer and transcriptional modulator within the transforming growth factor-beta (**TGF-beta**) signaling pathway. Upon activation by TGF-beta receptors, SMAD2 forms complexes with other SMAD proteins (notably SMAD4) and translocates to the nucleus, where it regulates the expression of target genes involved in diverse cellular processes such as proliferation, apoptosis, and differentiation. Through these functions, SMAD2 plays essential roles in embryonic development, tissue homeostasis, immune responses, and disease states including cancer.
- Other names
- SMAD family member 2MADH2Mothers against DPP homolog 2
02
Biological functions
Signal transduction (specifically TGF-beta signaling)Regulation of cell proliferationApoptosis regulationCell differentiation
03
Disease associations
Cancer (SMAD2 is implicated in tumorigenesis and cancer progression due to its role in TGF-beta signaling)Other (involvement in developmental disorders and fibrosis)
Beyond the preview
Go deeper on Mothers against decapentaplegic homolog 2 (SMAD2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mothers against decapentaplegic homolog 2 (SMAD2).